Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Classement en actions #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Prix de l'action
$93.80
Dernière synchronisation: 2025-04-28
Capitalisation boursière
$2.68B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Aerovate Therapeutics, Inc. (AVTE)

Catégorie

Historique du prix de l'action pour Aerovate Therapeutics, Inc. (AVTE)
Prix de clôture le plus élevé : $92.05 le 2025-04-01

Prix de clôture le plus bas : $799.05 le 2021-06-01
Historique du prix de l'action de Aerovate Therapeutics, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 1.25%
2024 -86.27%
2023 -23.84%
2022 125.16%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.63 -12.65%
AU
$762.91 6.87%
CH